Items where authors include "Toshner, M"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 12.

Article

Evans, RA, Leavy, OC, Richardson, M et al. (1003 more authors) (2022) Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. The Lancet Respiratory Medicine, 10 (8). pp. 761-775. ISSN 2213-2600

Kariotis, S orcid.org/0000-0001-9993-6017, Jammeh, E, Swietlik, EM et al. (98 more authors) (2021) Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood. Nature Communications, 12. 7104. ISSN 2041-1723

Swanson, PA, Padilla, M, Hoyland, W et al. (67 more authors) (2021) AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein-specific Th1 response with a diverse TCR repertoire. Science Translational Medicine, 13 (620). eabj7211. ISSN 1946-6234

Evans, RA, McAuley, H, Harrison, EM et al. (51 more authors) (2021) Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. The Lancet Respiratory Medicine, 9 (11). pp. 1275-1287. ISSN 2213-2600

Evans, RA, McAuley, H, Harrison, EM et al. (51 more authors) (2021) Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. The Lancet Respiratory Medicine, 9 (11). pp. 1275-1287. ISSN 2213-2600

Flaxman, A, Marchevsky, NG, Jenkin, D et al. (184 more authors) (2021) Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). The Lancet, 398 (10304). pp. 981-990. ISSN 0140-6736

Swanson, PA, Padilla, M, Hoyland, W et al. (63 more authors) (2021) T-cell mediated immunity after AZD1222 vaccination : a polyfunctional spike-specific Th1 response with a diverse TCR repertoire. medRxiv. (Submitted)

Emary, KRW, Golubchik, T, Aley, PK et al. (64 more authors) (2021) Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7) : an exploratory analysis of a randomised controlled trial. The Lancet, 397 (10282). pp. 1351-1362. ISSN 0140-6736

Voysey, M, Costa Clemens, SA, Madhi, SA et al. (763 more authors) (2021) Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. The Lancet, 397 (10277). pp. 881-891. ISSN 0140-6736

Voysey, M, Clemens, SAC, Madhi, SA et al. (80 more authors) (2020) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet, 397 (10269). pp. 99-111. ISSN 0140-6736

Wei, W, Tuna, S, Keogh, MJ et al. (426 more authors) (2019) Germline selection shapes human mitochondrial DNA diversity. Science, 364 (6442). 749-+. ISSN 0036-8075

Whitworth, J, Smith, PS, Martin, J-E et al. (330 more authors) (2018) Comprehensive cancer-predisposition gene testing in an adult multiple primary tumor series shows a broad range of deleterious variants and atypical tumor phenotypes. The American Journal of Human Genetics, 103 (1). pp. 3-18. ISSN 0002-9297

This list was generated on Sun Apr 21 20:58:20 2024 BST.